MoonLake Immunotherapeutics (MLTX)
52.02
+2.20
(+4.41%)
USD |
NASDAQ |
Nov 21, 16:00
52.02
0.00 (0.00%)
After-Hours: 19:56
MoonLake Immunotherapeutics Total Return Level: 49.82 for Nov. 20, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 20, 2024 | 49.82 |
November 19, 2024 | 49.33 |
November 18, 2024 | 48.54 |
November 15, 2024 | 48.83 |
November 14, 2024 | 52.50 |
November 13, 2024 | 51.06 |
November 12, 2024 | 51.89 |
November 11, 2024 | 53.89 |
November 08, 2024 | 51.78 |
November 07, 2024 | 50.67 |
November 06, 2024 | 51.48 |
November 05, 2024 | 47.63 |
November 04, 2024 | 46.40 |
November 01, 2024 | 46.76 |
October 31, 2024 | 46.42 |
October 30, 2024 | 47.00 |
October 29, 2024 | 48.19 |
October 28, 2024 | 48.05 |
October 25, 2024 | 46.70 |
October 24, 2024 | 46.20 |
October 23, 2024 | 46.59 |
October 22, 2024 | 48.00 |
October 21, 2024 | 49.02 |
October 18, 2024 | 48.94 |
October 17, 2024 | 48.08 |
Date | Value |
---|---|
October 16, 2024 | 49.12 |
October 15, 2024 | 48.00 |
October 14, 2024 | 48.90 |
October 11, 2024 | 48.94 |
October 10, 2024 | 47.00 |
October 09, 2024 | 47.69 |
October 08, 2024 | 49.85 |
October 07, 2024 | 51.74 |
October 04, 2024 | 55.28 |
October 03, 2024 | 52.00 |
October 02, 2024 | 51.82 |
October 01, 2024 | 51.72 |
September 30, 2024 | 50.42 |
September 27, 2024 | 49.40 |
September 26, 2024 | 51.37 |
September 25, 2024 | 50.81 |
September 24, 2024 | 54.26 |
September 23, 2024 | 55.40 |
September 20, 2024 | 54.04 |
September 19, 2024 | 53.71 |
September 18, 2024 | 53.11 |
September 17, 2024 | 50.99 |
September 16, 2024 | 49.98 |
September 13, 2024 | 51.14 |
September 12, 2024 | 51.04 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
4.69
Minimum
May 16 2022
63.86
Maximum
Feb 12 2024
24.66
Average
11.00
Median
Dec 11 2020
Total Return Level Benchmarks
Novartis AG | 241.23 |
AC Immune SA | 3.24 |
CRISPR Therapeutics AG | 47.26 |
Addex Therapeutics Ltd | 7.38 |
NLS Pharmaceutics Ltd | 3.29 |